Lengo Therapeutics has been acquired by Blueprint Medicines. Follow @Blueprint Medicines and visit the Blueprint Medicines website to learn more: https://www.blueprintmedicines.com/
View Top Employees from Lengo TherapeuticsWebsite | https://www.blueprintmedicines.com/ |
Ticker | BPMC |
Revenue | $66 million |
Funding | $745.3 million |
Employees | 730 (730 on RocketReach) |
Founded | 2020 |
Address | 3525 Del Mar Heights Rd Suite 1927, San Diego, California 92130, US |
Phone | (617) 374-7580 |
Technologies |
JavaScript,
HTML,
PHP
+56 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Oncology drug discovery, Healthcare, Science and Engineering, Oncology, Health Care, Genomically defined diseases, Medical, Rare diseases, Transformative drugs, Robust drug pipeline, Systemic mastocytosis, Hepatocellular carcinoma, Orphan drugs, Small molecules, Kinase inhibitor, Personalized medicine, Novel cancer therapies |
Web Rank | 3 Million |
Keywords | Blueprint Medicines, Blueprints In Oncology, Blueprint Medicines Pipeline, Liver Gist, Blu, Blueprint Investor Relations |
Competitors | AB Science, Deciphera Pharmaceuticals, G1 Therapeutics, Inc., Oncodesign Precision Medicine - OPM, TG Therapeutics, Inc. |
SIC | SIC Code 28 Companies, SIC Code 2833 Companies, SIC Code 283 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 42 Companies, NAICS Code 4242 Companies, NAICS Code 42421 Companies, NAICS Code 424 Companies |
Looking for a particular Lengo Therapeutics employee's phone or email?
The Lengo Therapeutics annual revenue was $66 million in 2024.
Christina Rossi is the COO of Lengo Therapeutics.
730 people are employed at Lengo Therapeutics.
Lengo Therapeutics is based in San Diego, California.
The NAICS codes for Lengo Therapeutics are [42, 4242, 42421, 424].
The SIC codes for Lengo Therapeutics are [28, 2833, 283, 87].